Skip to main content

Delays in Time to Treatment and Survival Impact in Breast Cancer

Abstract

Background

Time interval from diagnosis of breast cancer to treatment has been promulgated as one factor that can be used to evaluate cancer care quality. It remains controversial, however, whether a delay to treatment impacts survival. The purpose of this study was to evaluate whether delays from diagnosis to initial treatment in breast cancer impacts survival.

Materials and Methods

A retrospective review of patients undergoing breast cancer treatment between August 2005 and December 2008 in a comprehensive, multidisciplinary breast oncology program was undertaken. Two hospital systems were included: a county hospital (CH) treating a primarily minority, indigent population and a university hospital (UH) treating a primarily Caucasian, insured population. Interval to treatment, calculated from date of diagnosis to surgery, chemotherapy, or radiation treatment, and overall survival was compared between the two groups.

Results

A total of 1337 patients were included; 634 patients were treated in the CH and 703 in the UH. Interval to treatment was longer in the CH compared with the UH (53.4 ± 2.0 vs 33.2 ± 1.2 days; mean ± standard error of the mean [SEM], P < .0001). Patients treated at the CH had overall worse survival (P = .02); however, this difference did not hold true when controlled for stage. Additionally, when time to treatment was analyzed as an individual variable for all patients, there was no impact on survival.

Conclusions

Interval from diagnosis to treatment of breast cancer within the same cancer center was longer at the CH than the UH. There was, however, no effect on overall survival. Time to treatment may not be a meaningful indicator of cancer care quality.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56:168–83.

    Article  PubMed  Google Scholar 

  2. Moran MS, Goss D, Haffty BG, Kaufman CS, Winchester DP. Quality measures, standards, and accreditation for breast centers in the United States. Int J Radiat Oncol Biol Phys. 2010;76:1–4.

    PubMed  Google Scholar 

  3. Winchester DP, Stewart AK, Bura C, Jones RS. The National Cancer Data Base: a clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85:1–3.

    Article  PubMed  Google Scholar 

  4. Raval MV, Bilimoria KY, Stewart AK, Bentrem DJ, Ko CY. Using the NCDB for cancer care improvement: an introduction to available quality assessment tools. J Surg Oncol. 2009;99:488–90.

    Article  PubMed  Google Scholar 

  5. Kaufman CS, Shockney L, Rabinowitz B, Coleman C, Beard C, Landercasper J, et al. National Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010;17:377–85.

    CAS  Article  PubMed  Google Scholar 

  6. Lund MJ, Brawley OP, Ward KC, Young JL, Gabram SS, Eley JW. Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat. 2008;109:545–57.

    Article  PubMed  Google Scholar 

  7. Gorin SS, Heck JE, Cheng B, Smith SJ. Delays in breast cancer diagnosis and treatment by racial/ethnic group. Arch Intern Med. 2006;166:2244–52.

    Article  PubMed  Google Scholar 

  8. Smith ER, Adams SA, Das IP, Bottai M, Fulton J, Hebert JR. Breast cancer survival among economically disadvantaged women: the influences of delayed diagnosis and treatment on mortality. Cancer Epidemiol Biomarkers Prev. 2008;17:2882–90.

    Article  PubMed  Google Scholar 

  9. Pocock B, Nash S, Klein L, El-Tamer M, Schnabel FR, Joseph KA. Disparities in time to definitive surgical treatment between black and white women diagnosed with ductal carcinoma in situ. Am J Surg. 2007;194:521–3.

    Article  PubMed  Google Scholar 

  10. Neal RD, Allgar VL. Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the “National Survey of NHS Patients: Cancer”. Br J Cancer. 2005;92:1971–5.

    CAS  Article  PubMed  Google Scholar 

  11. Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119–26.

    CAS  Article  PubMed  Google Scholar 

  12. Fisher ER, Redmond C, Fisher B. A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer. 1977;40:3160–7.

    CAS  Article  PubMed  Google Scholar 

  13. Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst. 1996;88:1031–8.

    CAS  Article  PubMed  Google Scholar 

  14. Feldman JG, Saunders M, Carter AC, Gardner B. The effects of patient delay and symptoms other than a lump on survival in breast cancer. Cancer. 1983;51:1226–9.

    CAS  Article  PubMed  Google Scholar 

  15. Machiavelli M, Leone B, Romero A, Perez J, Vallejo C, Bianco A, et al. Relation between delay and survival in 596 patients with breast cancer. Oncology. 1989;46:78–82.

    CAS  Article  PubMed  Google Scholar 

  16. Dennis CR, Gardner B, Lim B. Analysis of survival and recurrence vs. patient and doctor delay in treatment of breast cancer. Cancer. 1975;35:714–20.

    CAS  Article  PubMed  Google Scholar 

  17. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999;79:858–64.

    CAS  Article  PubMed  Google Scholar 

  18. Sheridan B, Fleming J, Atkinson L, Scott G. The effects of delay in treatment on survival rates in carcinoma of the breast. Med J Aust. 1971;1:262–67.

    CAS  PubMed  Google Scholar 

  19. Wilkinson GS, Edgerton F, Wallace HJ, Reese P, Patterson J, Priore R. Delay, stage of disease and survival from breast cancer. J Chronic Dis. 1979;32:365–73.

    CAS  Article  PubMed  Google Scholar 

  20. Elwood M, Moorehead WP. Delay in diagnosis and long term survival in breast cancer. BMJ. 1980;280:1291–94.

    CAS  Article  PubMed  Google Scholar 

  21. Vernon S, Tilley B, Neale A, Steinfeldt L. Ethnicity, survival and delay in seeking treatment for symptoms of breast cancer. Cancer. 1985;55:1563–71.

    CAS  Article  PubMed  Google Scholar 

  22. Rabinovich M, Vallejo C, Perez J, Rodriguez R, Cuevas MA, Machiavelli MR, et al. Impact of delay to treatment upon survival in 1067 patients with breast cancer. Int J Oncol. 1993;2:197–201.

    Google Scholar 

  23. Raabe N, Fossaa S. Primary invasive breast carcinoma in Oslo 1980–1989: incidence and delay. Acta Oncol. 1996;35:9–15.

    CAS  Article  PubMed  Google Scholar 

  24. Gwyn K, Bondy ML, Cohen DS, Lund MJ, Liff JM, Flagg EW, et al. Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer. 2004;100:1595–604.

    Article  PubMed  Google Scholar 

  25. Coates RJ, Bransfield DD, Wesley M, Hankey B, Eley JW, Greenberg RS, et al. Differences between black and white women with breast cancer in time from symptom recognition to medical consultation. J Natl Cancer Inst. 1992;84:938–50.

    CAS  Article  PubMed  Google Scholar 

  26. Ganz PA. Quality of life across the continuum of breast cancer care. Breast J. 2000;6:324–30.

    Article  PubMed  Google Scholar 

  27. Barton MB, Morley DS, Moore S, Allen JD, Kleinman KP, Emmons KM, et al. Decreasing women’s anxieties after abnormal mammograms: a controlled trial. J Natl Cancer Inst. 2004;96:529–38.

    Article  PubMed  Google Scholar 

  28. Pineault P. Breast cancer screening: women’s experiences of waiting for further testing. Oncol Nurs Forum. 2007;34:847–53.

    Article  PubMed  Google Scholar 

  29. Thorne SE, Harris SR, Hislop TG, Vestrup JA. The experience of waiting for diagnosis after abnormal mammogram. Breast J. 1999;5:42–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roshni Rao MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Brazda, A., Estroff, J., Euhus, D. et al. Delays in Time to Treatment and Survival Impact in Breast Cancer. Ann Surg Oncol 17, 291–296 (2010). https://doi.org/10.1245/s10434-010-1250-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1250-6

Keywords

  • Breast Cancer
  • Breast Cancer Survival
  • Cancer Care
  • Inflammatory Breast Cancer
  • County Hospital